Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Perfusion Disorders”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Study completedNCT01348412
What this trial is testing

Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

Who this might be right for
Colorectal CancerLiver Metastases
Centre Georges Francois Leclerc 31
Not applicableLooking for participantsNCT07364474
What this trial is testing

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Who this might be right for
Uveal Melanoma
Massachusetts General Hospital 10
Testing effectiveness (Phase 2)Study completedNCT03089840
What this trial is testing

Normothermic Liver Preservation Trial

Who this might be right for
End Stage Liver DiseaseLiver Diseases
University of Alberta 106
Not applicableEnded earlyNCT02343016
What this trial is testing

NIRS as a Continuous Noninvasive Monitoring System of Liver/Kidney Graft Perfusion

Who this might be right for
Liver FailureKidney Failure
Mariella Enoc 15
Not applicableUnknownNCT04744389
What this trial is testing

Comparison of Hypothermic Versus Normothermic Ex-vivo Preservation.

Who this might be right for
End Stage Liver DIsease
Azienda Ospedaliero, Universitaria Pisana 60
Early research (Phase 1)Study completedNCT00001576
What this trial is testing

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Who this might be right for
Colorectal NeoplasmLiver NeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 28
Not applicableUnknownNCT03990623
What this trial is testing

CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization

Who this might be right for
Liver and Intrahepatic Bile Duct Carcinoma
M.D. Anderson Cancer Center 22
Not applicableNot Yet RecruitingNCT03946852
What this trial is testing

Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation

Who this might be right for
Liver Transplant; ComplicationsIschemia Reperfusion InjuryCirrhosis+3 more
London Health Sciences Centre 20
Not applicableStudy completedNCT03864497
What this trial is testing

Myocardial Perfusion Imaging in Liver Transplantation Candidates

Who this might be right for
Myocardial Perfusion ImagingLiver Failure
University Hospital Birmingham NHS Foundation Trust 403
Not applicableStudy completedNCT05045794
What this trial is testing

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

Who this might be right for
End Stage Liver DIseaseLiver Failure
Bridge to Life Ltd. 219
Post-approval studies (Phase 4)Study completedNCT02472249
What this trial is testing

Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 10
Early research (Phase 1)UnknownNCT02478151
What this trial is testing

Using Ex-vivo Normothermic Machine Perfusion With the Organox Metra™ Device to Store Human Livers for Transplantation

Who this might be right for
End-stage Liver Disease
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Study completedNCT00089401
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 8
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Not applicableActive Not RecruitingNCT07442214
What this trial is testing

View of Cerebral Perfusion in Liver Transplantation

Who this might be right for
End-stage Liver Disease (ESLD)Liver TransplantationCerebral Perfusion+1 more
Inonu University 43
Large-scale testing (Phase 3)UnknownNCT03086993
What this trial is testing

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Bile Duct CancerIntrahepatic Cholangiocarcinoma
Delcath Systems Inc. 295
Not applicableEnded earlyNCT01163526
What this trial is testing

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

Who this might be right for
Neuroendocrine TumorsBrain (Nervous System) CancersColon/Rectal Cancer+4 more
Stanford University 13
Not applicableLooking for participantsNCT07009132
What this trial is testing

Cholate Clearance in Fontan and Heart Failure

Who this might be right for
FontanRight Heart Failure
HepQuant, LLC 75
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT00103298
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute (NCI)
Load More Results